ANGO logo

AngioDynamics (ANGO) Cash From Financing

Annual CFF

-$64.25 M
-$89.67 M-352.75%

May 31, 2024

Summary

Performance

1-Year Change

-352.75%

3-Year Change

-278.24%

5-Year Change

-289.35%

15-Year Change

-69.15%

ANGO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.62%
ANGO annual cash flow from financing activities is higher than 9.62% of companies in Healthcare sector

High & Low

All-time High

$142.34 M
ANGO annual cash flow from financing activities is currently -145.14% below its historical high of $142.34 million

3-Year Low

-$64.25 M
ANGO annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

May 31, 2024
ANGO previous annual earnings announcement was published on May 31, 2024

Next Annual Earnings Report Date

N/A
ANGO next annual earnings announcement has not yet been scheduled

OtherANGOcash flowmetrics:

Annual CFI

$123.72 M
ANGO annual cash flow from investing activities is $123.72 million

Annual CFO

-$28.16 M
ANGO annual cash flow from operations is -$28.16 million

Annual FCF

-$33.93 M
ANGO annual free cash flow is -$33.93 million

Annual CAPEX

$5.77 M
ANGO annual capital expenditures is $5.77 million

Quarterly CFF

-$1.12 M
-$614.00 K-120.63%

November 30, 2024

Summary

Performance

3-Month Change

-120.63%

1-Year Change

+77.54%

3-Year Change

-219.21%

5-Year Change

-100%

ANGO Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

20.49%
ANGO quarterly cash flow from financing activities is higher than 20.49% of companies in Healthcare sector

High & Low

All-time High

$141.34 M
ANGO quarterly cash flow from financing activities is currently -100.79% below its historical high of $141.34 million

3-Year Low

-$59.59 M

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
ANGO previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
ANGO next earnings announcement is scheduled for Apr 4, 2025

OtherANGOcash flowmetrics:

Quarterly CFI

-$1.96 M
ANGO quarterly cash flow from investing activities is -$1.96 million

Quarterly CFO

$2.47 M
ANGO quarterly cash flow from operations is $2.47 million

Quarterly FCF

$1.68 M
ANGO quarterly free cash flow is $1.68 million

Quarterly CAPEX

$797.00 K
ANGO quarterly capital expenditures is $797.00 thousand

TTM CFF

-$5.94 M
-$771.00 K-14.92%

November 30, 2024

Summary

Performance

3-Month Change

-14.92%

1-Year Change

+90.76%

3-Year Change

+46.4%

5-Year Change

+96.12%

ANGO TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.29%
ANGO TTM cash flow from financing activities is higher than 16.29% of companies in Healthcare sector

High & Low

All-time High

$142.34 M
ANGO TTM cash flow from financing activities is currently -104.17% below its historical high of $142.34 million

3-Year Low

-$64.25 M

Earnings dates

Last Quarterly Earnings Report Date

Nov 30, 2024
ANGO previous earnings announcement was published on Nov 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
ANGO next earnings announcement is scheduled for Apr 4, 2025

OtherANGOcash flowmetrics:

TTM CFI

$22.70 M
ANGO TTM cash flow from investing activities is $22.70 million

TTM CFO

-$23.30 M
ANGO TTM cash flow from operations is -$23.30 million

TTM FCF

-$29.62 M
ANGO TTM free cash flow is -$29.62 million

TTM CAPEX

$6.31 M
ANGO TTM capital expenditures is $6.31 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ANGO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-352.8%+77.5%+90.8%
3 y3 years-278.2%-219.2%+46.4%
5 y5 years-289.4%-100.0%+96.1%

ANGO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-352.8%at low-104.6%+98.1%-122.3%+90.8%
5 y5-year-289.4%+32.5%-104.5%+98.1%-114.5%+96.1%
alltimeall time-145.1%+32.5%-100.8%+99.2%-104.2%+96.1%

AngioDynamics Cash From Financing History

DateAnnualQuarterlyTTM
Nov 2024
-
-$1.12 M(+120.6%)
-$5.94 M(+14.9%)
Aug 2024
-
-$509.00 K(-89.8%)
-$5.17 M(-92.0%)
May 2024
-$64.25 M(-352.7%)
-$5.00 M(-820.5%)
-$64.25 M(+8.4%)
Feb 2024
-
$694.00 K(-297.2%)
-$59.25 M(+0.4%)
Nov 2023
-
-$352.00 K(-99.4%)
-$59.00 M(+0.8%)
Aug 2023
-
-$59.59 M(<-9900.0%)
-$58.55 M(-330.3%)
May 2023
$25.42 M(+230.9%)
$0.00(-100.0%)
$25.42 M(-1.3%)
Feb 2023
-
$941.00 K(+813.6%)
$25.75 M(-0.1%)
Nov 2022
-
$103.00 K(-99.6%)
$25.77 M(-3.2%)
Aug 2022
-
$24.38 M(+7309.1%)
$26.61 M(+246.4%)
May 2022
-
$329.00 K(-65.9%)
$7.68 M(-467.4%)
May 2022
$7.68 M(-145.2%)
-
-
Feb 2022
-
$966.00 K(+2.5%)
-$2.09 M(-81.1%)
Nov 2021
-
$942.00 K(-82.7%)
-$11.08 M(-7.9%)
Aug 2021
-
$5.45 M(-157.7%)
-$12.03 M(-29.2%)
May 2021
-$16.99 M(-82.2%)
-$9.45 M(+17.7%)
-$16.99 M(-197.6%)
Feb 2021
-
-$8.02 M(>+9900.0%)
$17.41 M(-57.5%)
Nov 2020
-
-$10.00 K(-102.0%)
$40.99 M(-0.0%)
Aug 2020
-
$491.00 K(-98.0%)
$41.00 M(-143.0%)
May 2020
-$95.24 M(-380.7%)
$24.95 M(+60.3%)
-$95.24 M(-25.3%)
Feb 2020
-
$15.56 M(>+9900.0%)
-$127.43 M(-16.8%)
Nov 2019
-
$0.00(-100.0%)
-$153.07 M(+54.3%)
Aug 2019
-
-$135.75 M(+1774.5%)
-$99.17 M(-392.3%)
May 2019
$33.93 M(-393.7%)
-$7.24 M(-28.2%)
$33.93 M(-15.8%)
Feb 2019
-
-$10.08 M(-118.7%)
$40.31 M(-19.3%)
Nov 2018
-
$53.90 M(-2137.8%)
$49.97 M(-528.6%)
Aug 2018
-
-$2.65 M(+207.2%)
-$11.66 M(+0.9%)
May 2018
-$11.55 M(-69.6%)
-$861.00 K(+101.2%)
-$11.55 M(-33.1%)
Feb 2018
-
-$428.00 K(-94.5%)
-$17.26 M(-44.0%)
Nov 2017
-
-$7.72 M(+204.3%)
-$30.84 M(-20.4%)
Aug 2017
-
-$2.54 M(-61.4%)
-$38.72 M(+2.0%)
May 2017
-$37.98 M(+60.5%)
-$6.57 M(-53.1%)
-$37.98 M(+5.8%)
Feb 2017
-
-$14.01 M(-10.2%)
-$35.91 M(+25.2%)
Nov 2016
-
-$15.61 M(+768.4%)
-$28.70 M(+22.7%)
Aug 2016
-
-$1.80 M(-60.0%)
-$23.39 M(-1.2%)
May 2016
-$23.66 M(+126.1%)
-$4.50 M(-33.9%)
-$23.66 M(-21.8%)
Feb 2016
-
-$6.80 M(-34.0%)
-$30.27 M(+15.5%)
Nov 2015
-
-$10.30 M(+397.3%)
-$26.22 M(+158.4%)
Aug 2015
-
-$2.07 M(-81.4%)
-$10.14 M(-3.1%)
May 2015
-$10.46 M(-25.3%)
-$11.11 M(+305.3%)
-$10.46 M(-419.0%)
Feb 2015
-
-$2.74 M(-147.5%)
$3.28 M(+497.6%)
Nov 2014
-
$5.77 M(-341.4%)
$549.00 K(-103.4%)
Aug 2014
-
-$2.39 M(-190.6%)
-$16.14 M(+15.1%)
DateAnnualQuarterlyTTM
May 2014
-$14.02 M(+123.0%)
$2.64 M(-148.2%)
-$14.02 M(-23.9%)
Feb 2014
-
-$5.47 M(-49.9%)
-$18.41 M(+29.7%)
Nov 2013
-
-$10.91 M(+3911.8%)
-$14.20 M(+169.8%)
Aug 2013
-
-$272.00 K(-84.5%)
-$5.26 M(-16.3%)
May 2013
-$6.29 M(-104.4%)
-$1.76 M(+40.0%)
-$6.29 M(-104.6%)
Feb 2013
-
-$1.25 M(-36.6%)
$136.81 M(-1.6%)
Nov 2012
-
-$1.98 M(+52.6%)
$139.05 M(-0.2%)
Aug 2012
-
-$1.30 M(-100.9%)
$139.30 M(-2.1%)
May 2012
$142.34 M(+7305.7%)
$141.34 M(>+9900.0%)
$142.34 M(>+9900.0%)
Feb 2012
-
$992.00 K(-157.4%)
$1.11 M(-17.6%)
Nov 2011
-
-$1.73 M(-199.4%)
$1.34 M(-53.2%)
Aug 2011
-
$1.74 M(+1556.2%)
$2.88 M(+49.6%)
May 2011
$1.92 M(-29.3%)
$105.00 K(-91.5%)
$1.92 M(+6.4%)
Feb 2011
-
$1.23 M(-723.9%)
$1.81 M(-27.2%)
Nov 2010
-
-$197.00 K(-125.1%)
$2.48 M(-17.7%)
Aug 2010
-
$785.00 K(-7236.4%)
$3.01 M(+10.9%)
May 2010
$2.72 M(-132.9%)
-$11.00 K(-100.6%)
$2.72 M(+2.5%)
Feb 2010
-
$1.90 M(+464.7%)
$2.65 M(+106.5%)
Nov 2009
-
$337.00 K(-31.1%)
$1.28 M(+48.0%)
Aug 2009
-
$489.00 K(-743.4%)
$868.00 K(-110.5%)
May 2009
-$8.27 M(-305.9%)
-$76.00 K(-114.2%)
-$8.27 M(+15.0%)
Feb 2009
-
$535.00 K(-768.8%)
-$7.18 M(+13.8%)
Nov 2008
-
-$80.00 K(-99.1%)
-$6.31 M(+19.0%)
Aug 2008
-
-$8.64 M(-960.2%)
-$5.30 M(-232.1%)
May 2008
$4.01 M(-61.9%)
$1.00 M(-28.6%)
$4.01 M(+11.5%)
Feb 2008
-
$1.41 M(+51.6%)
$3.60 M(-67.4%)
Nov 2007
-
$929.00 K(+38.2%)
$11.04 M(+0.7%)
Aug 2007
-
$672.00 K(+13.7%)
$10.96 M(+4.1%)
May 2007
$10.53 M(-83.9%)
$591.00 K(-93.3%)
$10.53 M(-85.7%)
Feb 2007
-
$8.85 M(+942.3%)
$73.50 M(+12.4%)
Nov 2006
-
$849.00 K(+253.8%)
$65.38 M(+0.8%)
Aug 2006
-
$240.00 K(-99.6%)
$64.85 M(-0.9%)
May 2006
$65.42 M(+204.3%)
$63.56 M(+8619.3%)
$65.42 M(+2054.9%)
Feb 2006
-
$729.00 K(+132.2%)
$3.04 M(-16.3%)
Nov 2005
-
$314.00 K(-61.5%)
$3.63 M(+8.5%)
Aug 2005
-
$815.00 K(-30.8%)
$3.34 M(-84.5%)
May 2005
$21.50 M(-3189.1%)
$1.18 M(-10.8%)
$21.50 M(+5.8%)
Feb 2005
-
$1.32 M(+4455.2%)
$20.32 M(+7.0%)
Nov 2004
-
$29.00 K(-99.8%)
$19.00 M(+0.2%)
Aug 2004
-
$18.97 M
$18.97 M
May 2004
-$696.00 K(-121.1%)
-
-
May 2003
$3.31 M(+791.1%)
-
-
May 2002
$371.00 K
-
-

FAQ

  • What is AngioDynamics annual cash flow from financing activities?
  • What is the all time high annual CFF for AngioDynamics?
  • What is AngioDynamics annual CFF year-on-year change?
  • What is AngioDynamics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for AngioDynamics?
  • What is AngioDynamics quarterly CFF year-on-year change?
  • What is AngioDynamics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for AngioDynamics?
  • What is AngioDynamics TTM CFF year-on-year change?

What is AngioDynamics annual cash flow from financing activities?

The current annual CFF of ANGO is -$64.25 M

What is the all time high annual CFF for AngioDynamics?

AngioDynamics all-time high annual cash flow from financing activities is $142.34 M

What is AngioDynamics annual CFF year-on-year change?

Over the past year, ANGO annual cash flow from financing activities has changed by -$89.67 M (-352.75%)

What is AngioDynamics quarterly cash flow from financing activities?

The current quarterly CFF of ANGO is -$1.12 M

What is the all time high quarterly CFF for AngioDynamics?

AngioDynamics all-time high quarterly cash flow from financing activities is $141.34 M

What is AngioDynamics quarterly CFF year-on-year change?

Over the past year, ANGO quarterly cash flow from financing activities has changed by +$3.88 M (+77.54%)

What is AngioDynamics TTM cash flow from financing activities?

The current TTM CFF of ANGO is -$5.94 M

What is the all time high TTM CFF for AngioDynamics?

AngioDynamics all-time high TTM cash flow from financing activities is $142.34 M

What is AngioDynamics TTM CFF year-on-year change?

Over the past year, ANGO TTM cash flow from financing activities has changed by +$58.31 M (+90.76%)